<?xml version="1.0"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
      <journal-id journal-id-type="publisher-id">ijms</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Molecular Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1422-0067</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International (MDPI)</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmcid">3509634</article-id>
      <article-id pub-id-type="doi">10.3390/ijms131115177</article-id>
      <article-id pub-id-type="publisher-id">ijms-13-15177</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Detection of Glycomic Alterations Induced by Overexpression of P-Glycoprotein on the Surfaces of L1210 Cells Using Sialic Acid Binding Lectins</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bubenc&#xED;kova</surname>
            <given-names>Tatiana</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijms-13-15177">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cholujov&#xE1;</surname>
            <given-names>Dana</given-names>
          </name>
          <xref ref-type="aff" rid="af2-ijms-13-15177">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Messingerov&#xE1;</surname>
            <given-names>Lucia</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijms-13-15177">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mislovicova</surname>
            <given-names>Danica</given-names>
          </name>
          <xref ref-type="aff" rid="af3-ijms-13-15177">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seres</surname>
            <given-names>Mario</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijms-13-15177">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Breier</surname>
            <given-names>Albert</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijms-13-15177">1</xref>
          <xref ref-type="corresp" rid="c1-ijms-13-15177">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sulova</surname>
            <given-names>Zdena</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijms-13-15177">1</xref>
          <xref ref-type="corresp" rid="c1-ijms-13-15177">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-ijms-13-15177"><label>1</label>Institute of Molecular Physiology and Genetics, Center of Excellence of the Slovak Research and Development Agency &#x201C;BIOMEMBRANES2008&#x201D;, Slovak Academy of Sciences, Vlarska 5, Bratislava 83334, Slovakia; E-Mails: <email>tatiana.kurucova@savba.sk</email> (T.B.); <email>lucia.messingerova@savba.sk</email> (L.M.); <email>mario.seres@savba.sk</email> (M.S.)</aff>
      <aff id="af2-ijms-13-15177"><label>2</label>Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, Bratislava 83391, Slovakia; E-Mail:<email>dana.cholujova @savba.sk</email></aff>
      <aff id="af3-ijms-13-15177"><label>3</label>Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava 84538, Slovakia; E-Mail: <email>chemmisl@savba.sk</email></aff>
      <author-notes>
        <corresp id="c1-ijms-13-15177"><label>*</label>Authors to whom correspondence should be addressed: E-Mails: <email>Breier@up.upsav.sk</email> (A.B.); <email>zdena.sulova@savba.sk</email> (Z.S.); Tel.: +421-903-472606 (A.B.); +421-903-246360 (Z.S.); Fax: +421-2-54773666 (A.B.); +421-2-54773666 (Z.S.).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <volume>13</volume>
      <issue>11</issue>
      <fpage>15177</fpage>
      <lpage>15192</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>09</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
          <license-p><!--CREATIVE COMMONS-->This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>P-glycoprotein (P-gp) overexpression is the most frequently observed cause of multidrug resistance in neoplastic cells. In our experiments, P-gp was expressed in L1210 mice leukemia cells (S cells) by selection with vincristine (R cells) or transfection with the gene encoding human P-gp (T cells). Remodeling of cell surface sugars is associated with P-gp expression in L1210 cells as a secondary cellular response. In this study, we monitored the alteration of cell surface saccharides by <italic>Sambucus nigra</italic> agglutinin (SNA), wheat germ agglutinin (WGA) and <italic>Maackia amurensis</italic> agglutinin (MAA). Sialic acid is predominantly linked to the surface of S, R and T cells via &#x3B1;-2,6 branched sugars that tightly bind SNA. The presence of sialic acid linked to the cell surface via &#x3B1;-2,3 branched sugars was negligible, and the binding of MAA (recognizing this branch) was much less pronounced than SNA. WGA induced greater cell death than SNA, which was bound to the cell surface and agglutinated all three L1210 cell-variants more effectively than WGA. Thus, the ability of lectins to induce cell death did not correlate with their binding efficiency and agglutination potency. Compared to S cells, P-gp positive R and T cells contain a higher amount of <italic>N</italic>-acetyl-glucosamine on their cell surface, which is associated with improved WGA binding. Both P-gp positive variants of L1210 cells are strongly resistant to vincristine as P-gp prototypical drug. This resistance could not be altered by liberalization of terminal sialyl residues from the cell surface by sialidase.</p>
      </abstract>
      <kwd-group>
        <kwd>L1210 cells</kwd>
        <kwd>P-glycoprotein</kwd>
        <kwd>cell surface sugars</kwd>
        <kwd><italic>Sambucus nigra</italic> agglutinin</kwd>
        <kwd>wheat germ agglutinin</kwd>
        <kwd><italic>Maackia amurensis</italic> agglutinin</kwd>
        <kwd>sialic acid</kwd>
        <kwd>vincristine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>1. Introduction</title>
      <p>Multidrug resistance (MDR) of neoplastic cells represents an obstacle in the effective treatment of cancer with chemotherapy [<xref ref-type="bibr" rid="b1-ijms-13-15177">1</xref>]. Overexpression of the plasma membrane ABCB1 transporter, P-glycoprotein (P-gp), is generally accepted as the most frequent molecular cause for the development of MDR [<xref ref-type="bibr" rid="b2-ijms-13-15177">2</xref>]. P-gp overexpression is modulated by nuclear receptors that respond to the presence of xenobiotics as ligands in intracellular space (reviewed in [<xref ref-type="bibr" rid="b3-ijms-13-15177">3</xref>,<xref ref-type="bibr" rid="b4-ijms-13-15177">4</xref>]). While the activation of pregnane X and constitutive androstane receptors have been described to play a role in P-gp transcription control [<xref ref-type="bibr" rid="b5-ijms-13-15177">5</xref>,<xref ref-type="bibr" rid="b6-ijms-13-15177">6</xref>], we described retinoic acid receptors that may also play a partial role in this process [<xref ref-type="bibr" rid="b4-ijms-13-15177">4</xref>,<xref ref-type="bibr" rid="b7-ijms-13-15177">7</xref>]. P-glycoprotein (P-gp) is synthesized as a 145 kDa polypeptide that is glycosylated to a final molecular weight of approximately 175 kDa [<xref ref-type="bibr" rid="b8-ijms-13-15177">8</xref>,<xref ref-type="bibr" rid="b9-ijms-13-15177">9</xref>]. Massive expression of P-glycoprotein in the plasma membrane leads to the exposure of additive P-gp-linked glycosides, which alters the composition of cell surface sugars. Inhibition of P-gp <italic>N</italic>-glycosylation by tunicamycin leads to increased ubiquitination and the subsequent degradation of P-gp in several P-gp positive cell lines derived from solid tumors via drug selection or transfection with the gene encoding P-gp [<xref ref-type="bibr" rid="b10-ijms-13-15177">10</xref>]. However, tunicamycin may also induce P-gp expression at both the mRNA and protein levels that induces increased drug efflux activity in Fao hepatoma cells [<xref ref-type="bibr" rid="b11-ijms-13-15177">11</xref>]. We observed total depression of P-gp glycosylation induced by tunicamycin in two P-gp positive L1210 cell variants obtained either by selection with vincristine and or by transfection with the human gene encoding P-gp [<xref ref-type="bibr" rid="b12-ijms-13-15177">12</xref>]. Nevertheless, unglycosylated P-gp molecules were still present in the plasma membrane of treated cells, and their drug transport activity remained unchanged. Specific glycosylation of P-glycoprotein could be detected in the plasma membrane of P-gp positive cells by several lectins, such as <italic>Galanthus nivalis</italic> agglutinin (GNA) and <italic>Sambucus nigra</italic> agglutinin (SNA), using lectin blot procedure [<xref ref-type="bibr" rid="b8-ijms-13-15177">8</xref>]. However, after tunicamycin treatment of P-gp positive L1210 cells, unglycosylated P-gp could not be detected by either of these lectins [<xref ref-type="bibr" rid="b12-ijms-13-15177">12</xref>].</p>
      <p>In addition to the direct addition of P-gp-linked glycosides in cell surface sugars pattern, there are secondary alterations in the cell protein glycosylation pathway that are associated with MDR development [<xref ref-type="bibr" rid="b13-ijms-13-15177">13</xref>]. Strong depression of UDP-sugars is associated with decreases in glycogen and glycoprotein contents in P-gp positive L1210 cells [<xref ref-type="bibr" rid="b14-ijms-13-15177">14</xref>]. Moreover, the interaction between the plasma membrane of P-gp positive L1210 cells with a cationic dye, ruthenium red, was much less intense compared to their P-gp negative counterparts. These data indicated that negatively charged functional groups were depressed on the surface of the plasma membrane of P-gp positive L1210 cells [<xref ref-type="bibr" rid="b14-ijms-13-15177">14</xref>]. This negatively charged moiety is believed to be formed predominately by sialic acid (SA) on the cell surface [<xref ref-type="bibr" rid="b15-ijms-13-15177">15</xref>,<xref ref-type="bibr" rid="b16-ijms-13-15177">16</xref>]. Moreover, a decrease in the number of negative binding sites in the <italic>lamina externa</italic> of resistant cells is not only a sign of an alteration in oligo- and poly-saccharide metabolism but may be related also to changes in cellular aggregation, whereas resistant cells tend to form clusters [<xref ref-type="bibr" rid="b17-ijms-13-15177">17</xref>]. This tendency to aggregate may be determined by changes in the number and distribution of negative charges in the glycocalyx or the expression of adhesion molecules [<xref ref-type="bibr" rid="b18-ijms-13-15177">18</xref>].</p>
      <p>Csuka and Sugar previously described a depression in the agglutination of vincristine-colchicine resistant L1210 leukemic cells by <italic>concanavalin</italic> A (ConA) compared with sensitive L1210 leukemic cells [<xref ref-type="bibr" rid="b19-ijms-13-15177">19</xref>]. The alteration of cell surface sugars reduced ConA binding and elevated lectin (<italic>Lycopersicum esculentum</italic> agglutinin, LEA) binding to the cell surface of P-gp positive L1210 cells compared with their P-gp negative counterparts [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>]. However, both of these lectins failed to bind to saccharide parts directly linked to P-gp, suggesting considerable changes in the glycoside parts of glycoproteins that are distinct from P-gp in P-gp positive L1210 cells. A similar depression of ConA binding was observed following P-gp overexpression by selection of L1210 cells with vincristine or by transfection of L1210 cells with the human gene encoding P-gp [<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>]. Taken together, these data indicate that overexpression of P-gp in L1210 cells is directly associated with the physico-chemical alteration of the cell surface due to remodeling of the glycoside parts of several proteins in plasma membrane. These changes include differences in the exposure of negatively charged functional groups (probably SA) on the plasma membrane. Therefore, we sought to study of the interaction between the cell surface of P-gp negative and P-gp positive cells with SNA, lectin from <italic>Triticum vulgaris</italic> (wheat germ agglutinin&#x2013;WGA) and <italic>Maackia amurensis</italic> agglutinin (MAA), all of which are known as SA-specific lectins [<xref ref-type="bibr" rid="b22-ijms-13-15177">22</xref>]. In the present study, we used two variants of L1210 cells that highly express P-gp. These variants were obtained from parental cells (S) via stepwise adaptation to the vincristine (R) [<xref ref-type="bibr" rid="b23-ijms-13-15177">23</xref>] or stable transfection with the human gene encoding P-gp (T) [<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>].</p>
    </sec>
    <sec>
      <title>2. Results and Discussion</title>
      <sec>
        <title>2.1. Binding of WGA, MAA and SNA to Glycoproteins in the Crude Membrane Fraction of S, R and T cells</title>
        <p>Both of the P-gp positive L1210 cell variants, R and T, contained a massive amount of P-glycoprotein that could be detected by western blotting using an anti-P-gp antibody, c219 (<xref ref-type="fig" rid="f1-ijms-13-15177">Figure 1</xref>). In contrast, P-gp was not detectable in crude membrane fractions isolated from S cells. Similarly, both P-gp-positive L1210 cell variants expressed large amounts of P-gp mRNA, whereas this transcript was barely detectable [<xref ref-type="bibr" rid="b24-ijms-13-15177">24</xref>] or missing [<xref ref-type="bibr" rid="b12-ijms-13-15177">12</xref>,<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>,<xref ref-type="bibr" rid="b25-ijms-13-15177">25</xref>] in S cells. Both P-gp positive variants of L1210 cells (R and T) are strongly resistant to vincristine as prototypical P-gp substrate (<xref ref-type="supplementary-material" rid="s1-ijms-13-15177">Figure S1</xref>). SNA detected an approximately 170-kDa band in crude membrane fractions isolated from R and T cells. The corresponding signal was not visible in crude membrane fractions isolated from S cells (<xref ref-type="fig" rid="f1-ijms-13-15177">Figure 1</xref>). These data suggest that SNA binds directly to the saccharide parts of P-glycoprotein. We previously reported a similar direct interaction between P-gp and another lectin, GNA [<xref ref-type="bibr" rid="b12-ijms-13-15177">12</xref>]. Recently, P-gp has also been shown to directly interact with SNA and GNA [<xref ref-type="bibr" rid="b8-ijms-13-15177">8</xref>]. No protein bands were observed at the 170-kDa region in the presence of WGA and MAA in R and T cells (<xref ref-type="fig" rid="f1-ijms-13-15177">Figure 1</xref>). Similarly to WGA and MAA, also Con A and LEA failed to bind the glycosides linked to P-gp in our recent experiments [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>,<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>]. In contrast, LEA was described to interact with the 180 kDa glycoform of P-glycoprotein in rat brain capillary endothelia and MDR tumor cells [<xref ref-type="bibr" rid="b26-ijms-13-15177">26</xref>,<xref ref-type="bibr" rid="b27-ijms-13-15177">27</xref>]. This contrast may be explained by different glycosylation patterns of P-gp specific for different cell lines. There are more than 50 P-gp isoforms, which could present a range of differences within the glycome [<xref ref-type="bibr" rid="b8-ijms-13-15177">8</xref>].</p>
        <p>Changes in glycosylation of other proteins than P-gp may take place in P-gp positive L1210 cell variants because lectin blots of proteins in crude membrane fractions isolated from S, R and T cells with WGA, MAA and SNA revealed an alteration in the glycoprotein profiles between these three L1210 cell variants.</p>
      </sec>
      <sec>
        <title>2.2. Agglutinations and Cell death Effects of WGA, MAA and SNA on S, R and T Cells</title>
        <p>The agglutination efficiency in S, R and T cells by WGA, MAA and SNA were assessed by light microscopy and quantified as an aggregation factor ascertained using the CASY Model TT Cell Counter (see Materials and Methods). In the absence of lectins, S cells consist predominantly as single cells without the formation of cell aggregates (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>). In contrast, R and T cells tended to cluster under similar conditions. A slight but marginally significant elevation in the aggregation factor was observed for both P-gp positive L1210 cell variants (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>, <italic>p</italic> &lt; 0.1; R and T cells compared with S cells). We previously described a similar tendency for cell clustering in P-gp positive L1210 cell variants [<xref ref-type="bibr" rid="b17-ijms-13-15177">17</xref>]. All three of these lectins agglutinated S, R and T cells in a concentration-dependent manner (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>).</p>
        <p>WGA agglutinated S cells to a lower extent compared to R and T cells. This behavior was documented by aggregation factors (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>), which were significantly higher for R and T cells compared to S cells at all of the WGA concentration tested (the respective p values were between 0.001 &lt; <italic>p</italic> &lt; 0.02). Similarly to WGA, LEA also agglutinated P-gp positive L1210 cells more potently than their P-gp sensitive counterparts [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>]. In contrast, drug sensitive L1210 cells were agglutinated with ConA to a higher extent than their drug resistant variants [<xref ref-type="bibr" rid="b19-ijms-13-15177">19</xref>,<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>]. No significant differences were observed in the ability of WGA to agglutinate R and T cells. In contrast to WGA, MAA agglutinated S, R and T cells with similar efficiency, and no significant changes in the aggregation factors were observed (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>). SNA agglutinated all three variants of L1210 cells more potently than WGA and MAA, as indicated by the lower concentration of lectin necessary for massive cell aggregation (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>).</p>
        <p>SNA showed a slightly higher ability to agglutinate S cells than R and T cells, as shown by the lower aggregation factors obtained for R and T cell agglutination compared with S cell agglutination. These differences were marginally significant with probability value between 0.05 &lt; <italic>p</italic> &lt; 0.1.</p>
        <p>WGA exerted cytotoxic effects, to different extents depending on the cell line tested, in toxicity assays [<xref ref-type="bibr" rid="b28-ijms-13-15177">28</xref>]. In this study, WGA induced the most pronounced cell death of all three lectins tested (<xref ref-type="fig" rid="f3-ijms-13-15177">Figure 3</xref>). However, SNA was found to agglutinate all three L1210 cell variants more effectively than WGA (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>). Thus, cell aggregation due to agglutination by lectins is not a prevalent inducer of cell death effects in response to these two lectins. We previously made a similar assumption for the interaction between ConA and LEA with the cell surface of P-gp positive and negative L1210 cells [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>]. Thus, the cell death effects of several lectins involve specific interaction with several important glycoside parts of glycoproteins integrated in the plasma membrane, which damages crucial cell functions. Recently publish data regarding the cell death effect of lectin ArtinM on human myeloid leukemia cells is consistent with this assumption [<xref ref-type="bibr" rid="b29-ijms-13-15177">29</xref>]. P-gp negative S cells were less sensitive to WGA compared to the both P-gp positive cell variants (<xref ref-type="fig" rid="f3-ijms-13-15177">Figure 3</xref>). In contrast, SNA caused greater injury to S cells than to R and T cells. Only weak cell death effects were induced by MAA on all three of the L1220 cell variants (<xref ref-type="fig" rid="f3-ijms-13-15177">Figure 3</xref>).</p>
      </sec>
      <sec>
        <title>2.3. Binding of Fluorescein Isothiocyanate (FITC) Labeled WGA, MAA and SNA to the Cell Surface of S, R and T Cells</title>
        <p>FITC-linked lectins form a compact layer on the surface of L1210 cell variants that are visible by confocal microscopy (<xref ref-type="fig" rid="f4-ijms-13-15177">Figure 4</xref>). We observed similar labeling for FITC-ConA and FITC-LEA attached to the surface of P-gp negative and P-gp positive variants of L1210 cells [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>,<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>]. These data reveal that the indicated FITC linked lectins were not able to enter these cells under these experimental conditions because they were predominantly localized on the cell surface and not in the intracellular space (<xref ref-type="fig" rid="f4-ijms-13-15177">Figure 4</xref>). Cell surface binding of different lectins has also been described for several other cells types [<xref ref-type="bibr" rid="b30-ijms-13-15177">30</xref>&#x2013;<xref ref-type="bibr" rid="b34-ijms-13-15177">34</xref>]. Binding of FITC-labeled SNA was very intense to the cell surface of all three L1210 cell variants (<xref ref-type="fig" rid="f4-ijms-13-15177">Figure 4</xref>). The binding of FITC-labeled WGA and MAA were much less pronounced compared to SNA. Furthermore, the binding of SNA was slightly higher on S cells than R and T cells, but this difference was not significant. Alternatively, more intense WGA labeling was observed on both of the P-gp positive L1210 cell variants (R and T) compared to S cells as determined by confocal microscopy and FACS measurements (<xref ref-type="fig" rid="f4-ijms-13-15177">Figure 4</xref>). When the median fluorescent intensities were calculated from FACS histograms, Student&#x2019;s <italic>t</italic>-test revealed a significant difference between WGA binding onto P-gp negative S cells and P-gp positive R and T cells (<italic>p</italic> &lt; 0.05). Similarly, MAA interacted more intensely with the cell surface saccharides of R and T cells compared to S cells. However, this difference was only marginally significant (<italic>p</italic> &lt; 0.1, using Student&#x2019;s <italic>t</italic>-test).</p>
      </sec>
      <sec>
        <title>2.4. Effect of Sialidase Treatment on WGA, SNA and MAA Binding to the Cell Surface of S, R and T Cells</title>
        <p>All three lectin used in this paper are known to interact with sialyl-glycosides that are present on the cell glycocalyx [<xref ref-type="bibr" rid="b22-ijms-13-15177">22</xref>]. SA represents an important component of the cell surface negatively charged moieties that play an important role in cell adhesion and communication [<xref ref-type="bibr" rid="b35-ijms-13-15177">35</xref>,<xref ref-type="bibr" rid="b36-ijms-13-15177">36</xref>]. Overexpression of P-gp in L1210 cells resulted in the depression of negatively charged targets of the polycation dye, ruthenium red, on cell surface [<xref ref-type="bibr" rid="b14-ijms-13-15177">14</xref>,<xref ref-type="bibr" rid="b17-ijms-13-15177">17</xref>]. Ruthenium red has been proven to bind directly to cell surface sialyl residues [<xref ref-type="bibr" rid="b15-ijms-13-15177">15</xref>,<xref ref-type="bibr" rid="b16-ijms-13-15177">16</xref>,<xref ref-type="bibr" rid="b37-ijms-13-15177">37</xref>]. Therefore, we chose to study the effects of removing the terminal sialyl groups with sialidase (from <italic>V. cholerae</italic>) on the binding of WGA, MAA and SNA to the cell surface of all three L1210 cell variants. Treatment of S, R and T cells with sialidase liberated SA from the cell surface to the external medium (<xref ref-type="fig" rid="f5-ijms-13-15177">Figure 5</xref>). Treatment of S, R and T cells with sialidase did not alter the response of cells to vincristine (<xref ref-type="supplementary-material" rid="s1-ijms-13-15177">Figure S2</xref>), <italic>i.e.</italic>, R and T cells remained much less sensitive to this drug than S cells.</p>
        <p>Bacterial sialidases (EC 3.2.1.18) hydrolyze the &#x3B1;-2,3, &#x3B1;-2,6 and &#x3B1;-2,8 branched terminal SA residues from oligosaccharides, glycoproteins and glycolipids (<xref ref-type="fig" rid="f6-ijms-13-15177">Figure 6</xref>) [<xref ref-type="bibr" rid="b38-ijms-13-15177">38</xref>]. The net quantity of SA liberated following the incubation of R and T cells with sialidase was lower than that of S cells. These differences were found to be marginally significant (<italic>p</italic> &lt; 0.1), indicating that a slightly lower number of terminal sialic residues were accessible for sialidase on R and T cells compared to S cells. Positive signals observed with SA in control experiments (<italic>i.e.</italic>, after incubation of these cells in the absence of sialidase) were originated from materials (glycolipids, glycopeptides or oligosaccharides) released from cells to the external medium during the incubation of cells under non-growth condition in PBS.</p>
        <p>This release was more pronounced in P-gp positive R and T cells than in P-gp negative S cells, indicative of P-gp export activity. However, P-gp positive L1210 cells also exported metalloproteinases, important extracellular enzymes, to higher extent than their P-gp sensitive counterparts [<xref ref-type="bibr" rid="b39-ijms-13-15177">39</xref>]. The transmembrane efflux of metalloproteinases cannot be attributed to P-gp function, therefore the extrusion of intracellular materials to the extracellular medium, independent of P-gp efflux activity, should also be considered in this process.</p>
        <p>The removal of external SA improved the binding of FITC-WGA and FITC-MAA to the external surface of all three L1210 cell variants (<xref ref-type="fig" rid="f6-ijms-13-15177">Figure 6</xref>). In contrast, FITC-SNA was labeled cells after sialidase treatment to lower extend.</p>
        <p>All of the three lectins used in the current study are known as SA specific lectins [<xref ref-type="bibr" rid="b22-ijms-13-15177">22</xref>]. However, they differ in the terminal SA linkage to the oligosaccharide branch. The specificities of these lectins are documented in <xref ref-type="table" rid="t1-ijms-13-15177">Table 1</xref>.</p>
        <p>The binding of SNA to the cell surface of S, R and T cells was found to be higher than other two lectins. (<xref ref-type="fig" rid="f4-ijms-13-15177">Figures 4</xref> and <xref ref-type="fig" rid="f6-ijms-13-15177">6</xref>). This effect was associated primarily with amplified cell agglutination for SNA in comparison to MAA and WGA (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>).</p>
        <p>These results indicate that a majority of SA is linked to S, R and T cell surfaces via the &#x3B1;-2,6 branches that recognizes SNA and not via the &#x3B1;-2,3 branches that recognizes MAA. The removal of terminal SA by sialidase damages SNA ligands on the cell surface and therefore depressed SNA binding to all L1210 cell variants. In contrast to SNA, the removal of SA from cell surface of S, R and T cells by sialidase improved MAA binding, a result that seems to be controversial. This observation could be explained by a report by Knibbs <italic>et al.</italic>[<xref ref-type="bibr" rid="b41-ijms-13-15177">41</xref>], which demonstrated that SNA is required for the binding of disaccharides with the following structures: SA-5-acetyl-&#x3B1;-2,6-galactose or SA-5-acetyl-&#x3B1;-2,6-<italic>N</italic>-acetyl-galactosamine. These researchers also reported that MAA has a binding site complimentary to the trisaccharides SA-5-acetyl-&#x3B1;-2,3-galactose-1,4-<italic>N</italic>-acetyl-glussamine or SA-5-acetyl-&#x3B1;-2,3-galactose-1,4-glucose, to which sialic acid contributes less to the total binding affinity than SNA. Thus, if SA is linked to the surface of S, R and T cells via &#x3B1;-2,6 branches, this ligand could not be appropriate for MAA. However, removing sialic acid from this branching with sialidase may improve the exposure of internal saccharide structures (with MAA binding characteristics) on the surfaces of S and R and T cells and will consequently elevate MAA binding. The fact that SNA seems to interact (<xref ref-type="fig" rid="f4-ijms-13-15177">Figure 4</xref>), agglutinated (<xref ref-type="fig" rid="f2-ijms-13-15177">Figure 2</xref>) and damaged (<xref ref-type="fig" rid="f3-ijms-13-15177">Figure 3</xref>), more potently with S cells than R and T cells indicates that S cells contain a slightly higher amount of &#x3B1;-2,6 branched SA than R and T cells. In contrast, MAA interacts more effectively with the surface of R and T cells compared to S cells in sialidase treated or untreated cells (<xref ref-type="fig" rid="f6-ijms-13-15177">Figure 6</xref>), indicating that the internal saccharide structures that are ligands for MAA are exposed more effectively in P-gp positive cells (R and T) compared to P-gp negative (S) cells. WGA recognizes internal <italic>N</italic>-acetyl-glucosamine and bound less effectively to SA linked to <italic>N</italic>-acetyl-glucosamine and other structures (<xref ref-type="table" rid="t1-ijms-13-15177">Table 1</xref>). Removal of SA from the cell surface by sialidase treatment opens the structure of external cell glycocalyx and will increase the accessibility of <italic>N</italic>-acetyl-glucosamine and other WGA ligands to WGA, which will elevate WGA binding. Elevated binding of WGA was proven by the data in <xref ref-type="fig" rid="f6-ijms-13-15177">Figure 6</xref>. Structures that are ligands for WGA were found to be more accessible for WGA in P-gp positive R and T cells compared to P-gp negative S cells in either untreated or sialidase-treated cells. These structures seem to contain <italic>N</italic>-acetyl-glucosamine, and therefore this amino-sugar must be present in higher amounts on P-gp positive R and T cells compared to P-gp negative S cells. These data are consistent with more pronounced binding of LEA to P-gp positive than P-gp negative L1210 cell variants, as described in our previous paper [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>]. LEA recognizes chitin oligosaccharides that contain clusters of <italic>N</italic>-acetyl-glucosamines [<xref ref-type="bibr" rid="b42-ijms-13-15177">42</xref>]. Further studies are necessary to determine if WGA and MAA recognize common ligands on the surface of the L1210 cell variants used in this paper.</p>
        <p>Several authors have described any alterations of protein glycosylation status as consequence of treatment with anticancer agents [<xref ref-type="bibr" rid="b43-ijms-13-15177">43</xref>,<xref ref-type="bibr" rid="b44-ijms-13-15177">44</xref>]. These alterations were suggested to be caused by long term exposure of cancer cells to chemotherapeutic agents as side effect of cell adaptation/selection process. In the contrast, change in composition of cell surface sugars detected by specific lectins in the present paper seems to be directly related to P-gp overexpression and is independent on way by which P-gp expression was achieved. This suggestion could be deduced from fact that R and T cells show similar interaction with all three of the lectins applied in this study, and this behavior differs in S cells. Therefore, differences in SNA, WGA and MAA binding to R and S cells could not be attributed to process of cell adaptation/selection with vincristine.</p>
      </sec>
    </sec>
    <sec>
      <title>3. Experimental Section</title>
      <sec>
        <title>3.1. Cell Culture Conditions</title>
        <p>The following L1210 cell variants were used in this study: (i) S, drug-sensitive parental cells; (ii) R, P-gp-positive, drug-resistant cells that overexpress P-gp after selection with vincristine (VCR, purchased from Gedeon Richter Co., Hungary) [<xref ref-type="bibr" rid="b23-ijms-13-15177">23</xref>]; and (iii) T, P-gp-positive, drug-resistant cells that overexpress P-gp following stable transfection with the P-gp gene [<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>] using the Addgene plasmid, 10957 (pHaMDRwt), a retrovirus encoding the full-length P-gp cDNA [<xref ref-type="bibr" rid="b45-ijms-13-15177">45</xref>]. The cells (S, R and T; inoculums 1 &#xD7; 10<sup>6</sup> cells) were cultured in 4 mL RPMI 1640 media with <sc>l</sc>-glutamine (1 mg/mL), 4% fetal bovine serum and 1 &#x3BC;g/mL gentamycin (all purchased from Gibco, (Langley, OK, USA)) in a humidified atmosphere with 5% CO<sub>2</sub> and at 37 &#xB0;C. R cells were cultured for two passages without VCR prior to the experiments.</p>
      </sec>
      <sec sec-type="methods">
        <title>3.2. Western Blot and Lectin Blot Procedures</title>
        <p>P-gp and other membrane glycoproteins were detected by western blot and lectin blot procedures in crude membrane fractions isolated from S, R and T cells. Crude membrane fractions were prepared with a ProteomeExtract Subcellular Proteome Extraction Kit (Calbiochem, San Diego, CA, USA). Proteins in the samples were separated by sodium dodecyl sulfate polyacrylamide electrophoresis (SDS-PAGE) on polyacrylamide gradient gels (8&#x2013;16%). Proteins were then transferred by electroblotting to nitrocellulose membranes (GE Healthcare Europe GmbH, Vienna, Austria). The C219 anti-P-gp monoclonal antibody (Calbiochem, San Diego, CA, USA) was used to detect P-gp by western blot. An anti-mouse secondary antibody conjugated to horseradish peroxidase was used for detection with the aid of the ECL detection system (GE Healthcare Europe GmbH, Vienna, Austria) and a Kodak scanning system CF 440 (New Haven, CT, USA). For glycoprotein detection by lectin blots, WGA, MAA and SNA were conjugated with biotin (EY Laboratories Inc. San Mateo, CA, USA), and avidin was conjugated with horseradish peroxidase (Sigma, St. Louis, MO, USA). The peroxidase signals were detected using the ECL detection system and a Kodak CF 440 scanning system. Commassie blue (Sigma, St. Louis, MO, USA) staining of polyacrylamide gels was used to verify the accuracy of protein loading.</p>
      </sec>
      <sec>
        <title>3.3. Detection of S, R and T Cells Agglutination by WGA, MAA and SNA</title>
        <p>Cells (1 &#xD7; 10<sup>5</sup>) were incubated with different concentrations of WGA, MAA and SNA (EY Laboratories Inc., USA) in 1 mL of RPMI medium without bovine fetal serum for 2 h in a humidified atmosphere with 5% CO<sub>2</sub> at 37 &#xB0;C. Then, the agglutination of cells was monitored under a light microscope and aggregation factor was quantified using a CASY Model TT Cell Counter (Roche Applied Sciences, Indianapolis, IN, USA). The aggregation factor of a sample is automatically calculated as the quotient of the mean and peak cell volumes [<xref ref-type="bibr" rid="b46-ijms-13-15177">46</xref>].</p>
      </sec>
      <sec>
        <title>3.4. Effect of WGA, MAA and SNA on S, R and T Cell Survival</title>
        <p>As previously described [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>], cells were cultivated in 96-wells plates (5 &#xD7; 10<sup>4</sup> cells/well in 200 &#x3BC;L medium) in the absence or presence of different concentrations of WGA, MAA and SNA. After cultivation, cell viability was assessed by MTT test (Thiazolyl Blue Tetrazolium Bromide) [<xref ref-type="bibr" rid="b47-ijms-13-15177">47</xref>].</p>
      </sec>
      <sec>
        <title>3.5. Detection of FITC Labeled WGA, MAA and SNA Binding to the Surface of S, R and T Cells by Confocal Microscopy and Flow Cytometry</title>
        <p>After cultivation, cells were washed three times with PBS, resuspended in RPMI medium without fetal bovine serum (5 &#xD7; 10<sup>5</sup> cells/mL) and incubated for 60 min with FITC-labeled WGA, MAA and SNA (EY Laboratories Inc. San Mateo, CA, USA) at a concentration of 1 mg/L in a humidified atmosphere supplemented with 5% CO<sub>2</sub> at 37 &#xB0;C [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>]. After incubation, the cells were washed three times with PBS, and specific labels were evaluated by green fluorescence with a confocal laser-scanning microscope (LSM 510 META, Carl Zeiss) or were counted with a BD Accuri C6 flow cytometer (BD Bioscience, San Jose, CA, USA). In a special set of experiments, cells that showed prior interaction with FITC labeled lectins were treated with sialidase.</p>
      </sec>
      <sec>
        <title>3.6. Treatment of S, R and T cells with Sialidase and Estimation of the Amount of Sialic Acid Released from Cells to the External Medium</title>
        <p>Cells (1 &#xD7; 10<sup>7</sup>) were treated with sialidase from <italic>V. cholerae</italic> (Roche Applied Sciences, Indianapolis, IN, USA; 0.5 U/mL) in 1 mL of sterile phosphate buffered saline (PBS) containing 1% BSA (Merck Slovensko) and a protease inhibitor cocktail (Roche Applied Sciences, Indianapolis, IN, USA) for 10 hours. Next, cells were separated by centrifugation and used to estimate the binding of FITC-labeled WGA, MAA and SNA by FACS. Cell viability was monitored by propidium iodide staining using a BD Accuri C6 flow cytometer, and only propidium iodide negative cells were included in the FACS histograms. After centrifugation, the supernatants were used to estimate the amount of SA released with a thiobarbituric acid assay for sialic acids according to Warren&#x2019;s method [<xref ref-type="bibr" rid="b48-ijms-13-15177">48</xref>].</p>
      </sec>
      <sec sec-type="methods">
        <title>3.7. Statistical Analysis and Data Processing</title>
        <p>Numerical data are expressed as the mean &#xB1; SD of three independent measurements. Statistical significance was assessed using an unpaired Student&#x2019;s <italic>t</italic>-test using SigmaPlot Graphing Software (version 2.01; San Jose, CA, USA).</p>
        <p>The concentration dependent cytotoxic effects of WGA, MAA and SNA on cell viability were fitted according to an equation for exponential decay as previously described [<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>].</p>
      </sec>
    </sec>
    <sec>
      <title>4. Conclusions</title>
      <p>R and T cells show similar interaction with all three of the lectins applied in this study, and this behavior differs in S cells. In this study, we measured cell agglutination, cell death effects induced by lectins and lectin binding to cell surfaces (<xref ref-type="fig" rid="f2-ijms-13-15177">Figures 2</xref>&#x2013;<xref ref-type="fig" rid="f4-ijms-13-15177">4</xref> and <xref ref-type="fig" rid="f6-ijms-13-15177">6</xref>). Thus, alterations in the exposure of specific saccharide ligands for lectins on cell surface of L1210 cells is directly associated with the presence of P-gp in cells and is independent of means by which P-gp expression was achieved. As was previously hypothesized [<xref ref-type="bibr" rid="b3-ijms-13-15177">3</xref>,<xref ref-type="bibr" rid="b21-ijms-13-15177">21</xref>], this feature is involved in the complex remodeling of cell surface glycosides, which takes place as a secondary cellular response to P-gp expression in plasma membrane of L1210 cells.</p>
      <p>Sialic acid is linked to the surface of S, R and T cells, predominantly via &#x3B1;-2,6 branched sugars, resulting in massive binding of SNA. Binding of MAA was much less pronounced, indicating only a minor contribution of &#x3B1;-2,3 branched SA to the total pool of SA located on cell surface of all three L1210 cell variants. P-gp positive R and T cells should contain higher amounts of <italic>N</italic>-acetyl-glucosamine on their cell surface compared to S cells, which is consistent with heightened WGA binding.</p>
      <p>The cell death effect of lectins did not correlate with their binding efficiency and agglutination potency. Thus, the more pronounced cell death effect observed with WGA compared to SNA, which is more efficiently bound to the cell surface compared to WGA, indicates that the specific attachment of lectin to sugar parts of glycoprotein depresses its function and is essential for cell survival. A similar assumption can also be made for ConA-induced cell death effects in P-gp negative and positive L1210 cell variants, as described previously [<xref ref-type="bibr" rid="b20-ijms-13-15177">20</xref>].</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Information</title>
      <supplementary-material content-type="local-data" id="s1-ijms-13-15177">
        <media xlink:href="ijms-13-15177-s001.pdf" xlink:type="simple" id="d34e786" position="anchor" mimetype="application" mime-subtype="pdf"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This research was supported by funding from the Slovak grant agencies, <italic>i.e.</italic>, APVV grant agency numbers APVV-0084-07, APVV-0290-10, VVCE-0064-07 and VEGA grant agency numbers VEGA 2/0123/10, VEGA 2/0155/09, as well as funding from the Slovak Academy of Sciences for Centre of Excellence CEMAN. This contribution is the results of the projects implementation &#x201C;Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies&#x201D; ITMS 26240220058 and Centre of excellence for glycomics, ITMS 26240120031 supported by the Research &amp; Developmental Operational Programme funded by the ERDF.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="b1-ijms-13-15177">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perez-Tomas</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment</article-title>
          <source>Curr. Med. Chem</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>1859</fpage>
          <lpage>1876</lpage>
          <pub-id pub-id-type="pmid">16842198</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-ijms-13-15177">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Barancik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Uhrik</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy</article-title>
          <source>Curr. Cancer Drug Targets</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>457</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="pmid">16178819</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-ijms-13-15177">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gibalova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Seres</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Barancik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>New Insight into P-Glycoprotein as a Drug Target</article-title>
          <source>Anticancer Agents Med. Chem.</source>
          <year>2012</year>
          <comment>in press</comment>
        </element-citation>
      </ref>
      <ref id="b4-ijms-13-15177">
        <label>4</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Brtko</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Macejova</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Are Nuclear Receptors for Retinoids Involved in the Control of the Expression and Activity of P-Glycoprotein?</article-title>
          <source>Retinoic Acid: Structure, Mechanisms and Roles in Disease</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Cheng</surname>
              <given-names>L.-H.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <publisher-name>NOVA Publisher</publisher-name>
          <publisher-loc>New York, NY, USA</publisher-loc>
          <year>2012</year>
          <fpage>29</fpage>
          <lpage>52</lpage>
        </element-citation>
      </ref>
      <ref id="b5-ijms-13-15177">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cerveny</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Svecova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Anzenbacherova</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Vrzal</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Staud</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Dvorak</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Ulrichova</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Anzenbacher</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Pavek</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways</article-title>
          <source>Drug Metab. Dispos</source>
          <year>2007</year>
          <volume>35</volume>
          <fpage>1032</fpage>
          <lpage>1041</lpage>
          <pub-id pub-id-type="pmid">17392393</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-ijms-13-15177">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>G.N.</given-names>
            </name>
            <name>
              <surname>Hoque</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Cummins</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Bendayan</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells</article-title>
          <source>J. Neurochem</source>
          <year>2011</year>
          <volume>118</volume>
          <fpage>163</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">21517853</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-ijms-13-15177">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Macejova</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Seres</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sedlak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Brtko</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity</article-title>
          <source>Toxicol. In Vitro</source>
          <year>2008</year>
          <volume>22</volume>
          <fpage>96</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">17920233</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-ijms-13-15177">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greer</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Ivey</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Distinct <italic>N</italic>-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2007</year>
          <volume>1770</volume>
          <fpage>1275</fpage>
          <lpage>1282</lpage>
          <pub-id pub-id-type="pmid">17692467</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-ijms-13-15177">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loo</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Bartlett</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein</article-title>
          <source>Biochem. Biophys. Res. Commun</source>
          <year>2004</year>
          <volume>325</volume>
          <fpage>580</fpage>
          <lpage>585</lpage>
          <pub-id pub-id-type="pmid">15530432</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-ijms-13-15177">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Hait</surname>
              <given-names>W.N.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the stability of P-glycoprotein by ubiquitination</article-title>
          <source>Mol. Pharmacol</source>
          <year>2004</year>
          <volume>66</volume>
          <fpage>395</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="pmid">15322230</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-ijms-13-15177">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ledoux</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Friedlander</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Laouari</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Glucose depletion enhances P-glycoprotein expression in hepatoma cells: Role of endoplasmic reticulum stress response</article-title>
          <source>Cancer Res</source>
          <year>2003</year>
          <volume>63</volume>
          <fpage>7284</fpage>
          <lpage>7290</lpage>
          <pub-id pub-id-type="pmid">14612525</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-ijms-13-15177">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seres</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cholujova</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bubencikova</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in l1210 cells</article-title>
          <source>Int. J. Mol. Sci</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>7772</fpage>
          <lpage>7784</lpage>
          <pub-id pub-id-type="pmid">22174631</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-ijms-13-15177">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Miao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Glycomic alterations are associated with multidrug resistance in human leukemia</article-title>
          <source>Int. J. Biochem. Cell Biol</source>
          <year>2012</year>
          <volume>44</volume>
          <fpage>1244</fpage>
          <lpage>1253</lpage>
          <pub-id pub-id-type="pmid">22579717</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-ijms-13-15177">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fiala</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>El-Saggan</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Uhrik</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Liptaj</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Dovinova</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Hanusovska</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Drobna</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Barancik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2003</year>
          <volume>1639</volume>
          <fpage>213</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">14636953</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-ijms-13-15177">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luft</surname>
              <given-names>J.H.</given-names>
            </name>
          </person-group>
          <article-title>Ruthenium red and violet. II. Fine structural localization in animal tissues</article-title>
          <source>Anat. Rec</source>
          <year>1971</year>
          <volume>171</volume>
          <fpage>369</fpage>
          <lpage>415</lpage>
          <pub-id pub-id-type="pmid">4108334</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-ijms-13-15177">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luft</surname>
              <given-names>J.H.</given-names>
            </name>
          </person-group>
          <article-title>Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy and mechanism of action</article-title>
          <source>Anat. Rec</source>
          <year>1971</year>
          <volume>171</volume>
          <fpage>347</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">4108333</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-ijms-13-15177">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uhrik</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>El-Saggan</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Seres</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gibalova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Structural differences between sensitive and resistant L1210 cells</article-title>
          <source>Gen. Physiol. Biophys</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>427</fpage>
          <lpage>438</lpage>
          <pub-id pub-id-type="pmid">17356234</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-ijms-13-15177">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vitte</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Benoliel</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Pierres</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bongrand</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of cell adhesion</article-title>
          <source>Clin. Hemorheol. Microcirc</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>167</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">16215283</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-ijms-13-15177">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Csuka</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Sugar</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Cell surface properties of L1210 leukaemia cells</article-title>
          <source>Acta Morphol. Acad. Sci. Hung</source>
          <year>1976</year>
          <volume>24</volume>
          <fpage>297</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">1032277</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-ijms-13-15177">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Mislovicova</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gibalova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Vajcnerova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Polakova</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Uhrik</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Tylkova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kovarova</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sedlak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides</article-title>
          <source>J. Proteome Res</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>513</fpage>
          <lpage>520</lpage>
          <pub-id pub-id-type="pmid">19099507</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-ijms-13-15177">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Ditte</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kurucova</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Polakova</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rogozanova</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gibalova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Seres</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Skvarkova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sedlak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pastorek</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The presence of P-glycoprotein in L1210 cells directly induces down-regulation of cell surface saccharide targets of concanavalin A</article-title>
          <source>Anticancer Res</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>3661</fpage>
          <lpage>3668</lpage>
          <pub-id pub-id-type="pmid">20944151</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-ijms-13-15177">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lehmann</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Tiralongo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tiralongo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Sialic acid-specific lectins: occurrence, specificity and function</article-title>
          <source>Cell Mol. Life Sci</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>1331</fpage>
          <lpage>1354</lpage>
          <pub-id pub-id-type="pmid">16596337</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-ijms-13-15177">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polekova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Barancik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mrazova</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Pirker</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wallner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein</article-title>
          <source>Neoplasma</source>
          <year>1992</year>
          <volume>39</volume>
          <fpage>73</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">1356238</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-ijms-13-15177">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gibalova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Seres</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rusnak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ditte</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Labudova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Uhrik</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Pastorek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sedlak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation</article-title>
          <source>Toxicol. In Vitro</source>
          <year>2012</year>
          <volume>26</volume>
          <fpage>435</fpage>
          <lpage>444</lpage>
          <pub-id pub-id-type="pmid">22269388</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-ijms-13-15177">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seres</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ditte</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Effect of thapsigargin on P-glycoprotein-negative and P-glycoprotein-positive L1210 mouse leukaemia cells</article-title>
          <source>Gen. Physiol. Biophys</source>
          <year>2010</year>
          <volume>29</volume>
          <fpage>396</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="pmid">21157003</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-ijms-13-15177">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fakla</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Hever</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Molnar</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Tomato lectin labels the 180 kD glycoform of P-glycoprotein in rat brain capillary endothelia and mdr tumor cells</article-title>
          <source>Anticancer Res</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>3107</fpage>
          <lpage>3111</lpage>
          <pub-id pub-id-type="pmid">9713518</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-ijms-13-15177">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molnar</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kars</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Gunduz</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Engi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>van Damme</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Peumans</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Makovitzky</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gyemant</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Molnar</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Interaction of tomato lectin with ABC transporter in cancer cells: Glycosylation confers functional conformation of P-gp</article-title>
          <source>Acta Histochem</source>
          <year>2009</year>
          <volume>111</volume>
          <fpage>329</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="pmid">19124148</pub-id>
        </element-citation>
      </ref>
      <ref id="b28-ijms-13-15177">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dalla Pellegrina</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Matucci</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zoccatelli</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rizzi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Vincenzi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Veneri</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Andrighetto</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Peruffo</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Chignola</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Studies on the joint cytotoxicity of Wheat Germ Agglutinin and monensin</article-title>
          <source>Toxicol. In Vitro</source>
          <year>2004</year>
          <volume>18</volume>
          <fpage>821</fpage>
          <lpage>827</lpage>
          <pub-id pub-id-type="pmid">15465648</pub-id>
        </element-citation>
      </ref>
      <ref id="b29-ijms-13-15177">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Tamarozzi</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Rego</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Roque-Barreira</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>The recognition of <italic>N</italic>-glycans by the lectin ArtinM mediates cell death of a human myeloid leukemia cell line</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e27892</fpage>
          <pub-id pub-id-type="pmid">22132163</pub-id>
        </element-citation>
      </ref>
      <ref id="b30-ijms-13-15177">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aubery</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Reynier</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ogier-Denis</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Font</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bardin</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>WGA binding to the surface of two autologous human melanoma cell lines: different expression of sialyl and <italic>N</italic>-acetylglucosaminyl residues</article-title>
          <source>Cell Biol. Int. Rep</source>
          <year>1990</year>
          <volume>14</volume>
          <fpage>275</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">2344628</pub-id>
        </element-citation>
      </ref>
      <ref id="b31-ijms-13-15177">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ree</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Lectin histochemistry of malignant tumors. II. Concanavalin A: A new histochemical marker for macrophage-histiocytes in follicular lymphoma</article-title>
          <source>Cancer</source>
          <year>1983</year>
          <volume>51</volume>
          <fpage>1639</fpage>
          <lpage>1646</lpage>
          <pub-id pub-id-type="pmid">6187429</pub-id>
        </element-citation>
      </ref>
      <ref id="b32-ijms-13-15177">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ree</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>Lectin histochemistry of malignant tumors. I. Peanut agglutinin (PNA) receptors in follicular lymphoma and follicular hyperplasia: An immunohistochemical study</article-title>
          <source>Cancer</source>
          <year>1983</year>
          <volume>51</volume>
          <fpage>1631</fpage>
          <lpage>1638</lpage>
          <pub-id pub-id-type="pmid">6339030</pub-id>
        </element-citation>
      </ref>
      <ref id="b33-ijms-13-15177">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ree</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Raine</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Crowley</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Lectin binding patterns in diffuse large cell lymphoma</article-title>
          <source>Cancer</source>
          <year>1983</year>
          <volume>52</volume>
          <fpage>2089</fpage>
          <lpage>2099</lpage>
          <pub-id pub-id-type="pmid">6194878</pub-id>
        </element-citation>
      </ref>
      <ref id="b34-ijms-13-15177">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vetri</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Carrotta</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Picone</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>di Carlo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Militello</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Concanavalin A aggregation and toxicity on cell cultures</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2010</year>
          <volume>1804</volume>
          <fpage>173</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="pmid">19782769</pub-id>
        </element-citation>
      </ref>
      <ref id="b35-ijms-13-15177">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rutishauser</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Polysialic acid at the cell surface: Biophysics in service of cell interactions and tissue plasticity</article-title>
          <source>J. Cell Biochem</source>
          <year>1998</year>
          <volume>70</volume>
          <fpage>304</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">9706867</pub-id>
        </element-citation>
      </ref>
      <ref id="b36-ijms-13-15177">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soeiro</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>Silva-Filho</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Meirelles</surname>
              <given-names>M.N.</given-names>
            </name>
          </person-group>
          <article-title>The nature of anionic sites and the endocytic pathway in heart muscle cells</article-title>
          <source>J. Submicrosc. Cytol. Pathol</source>
          <year>1994</year>
          <volume>26</volume>
          <fpage>121</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">8149329</pub-id>
        </element-citation>
      </ref>
      <ref id="b37-ijms-13-15177">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wieraszko</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Evidence that ruthenium red disturbs the synaptic transmission in the rat hippocampal slices through interacting with sialic acid residues</article-title>
          <source>Brain Res</source>
          <year>1986</year>
          <volume>378</volume>
          <fpage>120</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="pmid">2427153</pub-id>
        </element-citation>
      </ref>
      <ref id="b38-ijms-13-15177">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Features and applications of bacterial sialidases</article-title>
          <source>Appl. Microbiol. Biotechnol</source>
          <year>2011</year>
          <volume>91</volume>
          <fpage>1</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">21544654</pub-id>
        </element-citation>
      </ref>
      <ref id="b39-ijms-13-15177">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barancik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bohacova</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Gibalova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sedlak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sulova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Potentiation of anticancer drugs: Effects of pentoxifylline on neoplastic cells</article-title>
          <source>Int. J. Mol. Sci</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>369</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="pmid">22312258</pub-id>
        </element-citation>
      </ref>
      <ref id="b40-ijms-13-15177">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thies</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Moll</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation</article-title>
          <source>Br. J. Cancer</source>
          <year>2001</year>
          <volume>84</volume>
          <fpage>819</fpage>
          <lpage>823</lpage>
          <pub-id pub-id-type="pmid">11259098</pub-id>
        </element-citation>
      </ref>
      <ref id="b41-ijms-13-15177">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knibbs</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>I.J.</given-names>
            </name>
            <name>
              <surname>Ratcliffe</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Shibuya</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins</article-title>
          <source>J. Biol. Chem</source>
          <year>1991</year>
          <volume>266</volume>
          <fpage>83</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">1985926</pub-id>
        </element-citation>
      </ref>
      <ref id="b42-ijms-13-15177">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garner</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>A.N.</given-names>
            </name>
            <name>
              <surname>Horst</surname>
              <given-names>M.N.</given-names>
            </name>
          </person-group>
          <article-title>Morphologic and biochemical studies of chitin expression in Pneumocystis carinii</article-title>
          <source>J. Protozool</source>
          <year>1991</year>
          <volume>38</volume>
          <fpage>12S</fpage>
          <lpage>14S</lpage>
          <pub-id pub-id-type="pmid">1818131</pub-id>
        </element-citation>
      </ref>
      <ref id="b43-ijms-13-15177">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Graaf</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Slot</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>van Dijk</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Changes in glycosylation of L1210 cells after exposure to various antimetabolites</article-title>
          <source>Eur. J. Cancer</source>
          <year>1993</year>
          <volume>29A</volume>
          <fpage>1760</fpage>
          <lpage>1765</lpage>
          <pub-id pub-id-type="pmid">8398306</pub-id>
        </element-citation>
      </ref>
      <ref id="b44-ijms-13-15177">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>X.J.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Garfield</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gottesman</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines</article-title>
          <source>Cancer Res</source>
          <year>2003</year>
          <volume>63</volume>
          <fpage>5909</fpage>
          <lpage>5916</lpage>
          <pub-id pub-id-type="pmid">14522917</pub-id>
        </element-citation>
      </ref>
      <ref id="b45-ijms-13-15177">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pastan</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Gottesman</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lovelace</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rutherford</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Willingham</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1988</year>
          <volume>85</volume>
          <fpage>4486</fpage>
          <lpage>4490</lpage>
          <pub-id pub-id-type="pmid">2898143</pub-id>
        </element-citation>
      </ref>
      <ref id="b46-ijms-13-15177">
        <label>46</label>
        <element-citation publication-type="webpage">
          <source>Cell Counter + Analyser System Model TT, Operator Manual</source>
          <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.ibgm.med.uva.es/files/upload/manual//casyoperatormanual.pdf">http://www.ibgm.med.uva.es/files/upload/manual//casyoperatormanual.pdf</ext-link></comment>
          <date-in-citation>accessed on 30 April 2002</date-in-citation>
        </element-citation>
      </ref>
      <ref id="b47-ijms-13-15177">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerlier</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Thomasset</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Use of MTT colorimetric assay to measure cell activation</article-title>
          <source>J. Immunol. Methods</source>
          <year>1986</year>
          <volume>94</volume>
          <fpage>57</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">3782817</pub-id>
        </element-citation>
      </ref>
      <ref id="b48-ijms-13-15177">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warren</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>The thiobarbituric acid assay of sialic acids</article-title>
          <source>J. Biol. Chem</source>
          <year>1959</year>
          <volume>234</volume>
          <fpage>1971</fpage>
          <lpage>1975</lpage>
          <pub-id pub-id-type="pmid">13672998</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-ijms-13-15177" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Detection of protein bands in the crude membrane fraction of S, R and T cells by Commassie blue staining of polyacrylamide gels. Wheat germ agglutinin (WGA), <italic>Maackia amurensis</italic> agglutinin (MAA) and <italic>Sambucus nigra</italic> agglutinin (SNA) were detected using lectin blots and western blotting with the c219 anti-P-gp antibody. Polyacrylamide gels were stained with Commassie blue as a control for the accuracy of protein loading. These data are representative of three independent experiments.</p>
      </caption>
      <graphic xlink:href="ijms-13-15177f1"/>
    </fig>
    <fig id="f2-ijms-13-15177" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Monitoring of S, R and T cell agglutination by WGA, MAA and SNA. After incubation with lectins (see materials and methods), cells were studied by light microscopy and counted using the CASY Model TT Cell Counter. Microscopic images are representative of three independent experiments. Data are presented as the mean &#xB1; SD of three independent experiments.</p>
      </caption>
      <graphic xlink:href="ijms-13-15177f2"/>
    </fig>
    <fig id="f3-ijms-13-15177" position="float">
      <label>Figure 3</label>
      <caption>
        <p>WGA, MAA and SNA induced cell death in S, R and T cells. Cell death was assessed after incubation with lectins (see materials and methods) by spectrophotometric MTT test. Control experiment in the absence of lectins was arbitrarily chosen as 1. Data represent mean &#xB1; SD from three independent experiments. Cell death effects induced by WGA and SNA in S cells <italic>vs.</italic> R or T cells were significantly different (0.002 &lt; <italic>p</italic> &lt; 0.02) for all concentrations tested. In R and T cells, differences in cell death in response to these two lectins were not significant. No significant effects on cell death were observed with MAA in all three L1210 cell variants.</p>
      </caption>
      <graphic xlink:href="ijms-13-15177f3"/>
    </fig>
    <fig id="f4-ijms-13-15177" position="float">
      <label>Figure 4</label>
      <caption>
        <p>SNA, WGA and MAA binding to the cell surface of S, R and T cells. Cells were studied by confocal microscopy after incubation with Fluorescein Isothiocyanate (FITC) linked lectins (see materials and methods) and were quantified using FACS. The red histograms represent controls in which cells were incubated in the absence of FITC labeled lectins prior to measurement. These data are representative of three independent measurements.</p>
      </caption>
      <graphic xlink:href="ijms-13-15177f4"/>
    </fig>
    <fig id="f5-ijms-13-15177" position="float">
      <label>Figure 5</label>
      <caption>
        <p>Sialidase induced liberation of sialic acid from S, R and T cells to the external medium. Sialic acid contents were quantified in the external medium after the incubation of cells with sialidase in phosphate buffered saline (PBS) for 10 h (E). As a control, external medium was added after incubation of the cells in the absence of sialidase (C). The net amount of sialic acid liberated by the sialidase reaction represents the difference (E-C). Data represent the mean &#xB1; SD of three independent experiments.</p>
      </caption>
      <graphic xlink:href="ijms-13-15177f5"/>
    </fig>
    <fig id="f6-ijms-13-15177" position="float">
      <label>Figure 6</label>
      <caption>
        <p>Effects of sialidase treatment on WGA, MAA and SNA binding to S, R and T cells. Sialidase-induced removal of external sialic acid is schematically shown in the upper left panel. Cells incubated in the absence (C) or presence (D) of sialidase were left to interact with FITC-WGA, FITC-MAA and FITC-SNA (CL and DL). Cells incubated in the absence of FITC labeled lectins (C, D) were used as control. FACS histograms are representative of three independent measurements. The median fluorescence intensity data represent the mean &#xB1; SD of three independent experiments. Differences between the median fluorescent intensity were significant when comparing CL and DL with the following probabilities for WGA binding to: S cells&#x2014;<italic>p</italic> &lt; 0.02, R cells&#x2014;<italic>p</italic> &lt; 0.01 and T cells&#x2014;<italic>p</italic> &lt;0.01; MAA binding to S cells&#x2014;<italic>p</italic> &lt; 0.02, R cells&#x2014;<italic>p</italic> &lt; 0.01 and T cells&#x2014; <italic>p</italic>&lt; 0.01; and SNA binding to S cells&#x2014;<italic>p</italic> &lt; 0.005, R cells&#x2014;<italic>p</italic> &lt; 0.01 and T cells&#x2014;<italic>p</italic> &lt; 0.01.</p>
      </caption>
      <graphic xlink:href="ijms-13-15177f6"/>
    </fig>
    <table-wrap id="t1-ijms-13-15177" position="float">
      <label>Table 1</label>
      <caption>
        <p>Ligand specificity of WGA, MAA and SNA.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="center" valign="bottom" rowspan="1" colspan="1">Lectin from</th>
            <th align="center" valign="bottom" rowspan="1" colspan="1">Abbreviation</th>
            <th align="center" valign="bottom" rowspan="1" colspan="1">Specificity</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1"><italic>Triticum vulgaris</italic> (Wheat germ)</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">WGA</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Internal &#x3B2;-<sc>d</sc>-<italic>N</italic>-acetyl glucosamine&gt; &#x3B2;-<sc>d</sc>-<italic>N</italic>-acetyl glucosamine&#x2013;SA &gt; <italic>N</italic>-acetyl galactosamine &gt; lactose &gt; galalactose</td>
          </tr>
          <tr>
            <td align="center" valign="top" rowspan="1" colspan="1">
              <italic>Maackia amurensis</italic>
            </td>
            <td align="center" valign="top" rowspan="1" colspan="1">MAA</td>
            <td align="center" valign="top" rowspan="1" colspan="1">&#x3B1;-2,3 branched SA</td>
          </tr>
          <tr>
            <td align="center" valign="top" rowspan="1" colspan="1">
              <italic>Sambucus nigra</italic>
            </td>
            <td align="center" valign="top" rowspan="1" colspan="1">SNA</td>
            <td align="center" valign="top" rowspan="1" colspan="1">&#x3B1;-2,6 branched SA</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1-ijms-13-15177">
          <p>Data were adopted from [<xref ref-type="bibr" rid="b22-ijms-13-15177">22</xref>,<xref ref-type="bibr" rid="b40-ijms-13-15177">40</xref>].</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
